Average Co-Inventor Count = 7.37
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (12 from 1,536 patents)
2. Centrexion Therapeutics Corporation (6 from 36 patents)
3. Vitae Pharmaceuticals, Inc. (1 from 85 patents)
4. Hydra Biosciences, Inc. (1 from 49 patents)
5. Boehringer Ingelheim Pharma Gmbh & Co Kg (194 patents)
18 patents:
1. 12344601 - (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
2. 11725004 - (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
3. 11084810 - (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
4. 10570125 - (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
5. 10329292 - Substituted xanthine derivatives
6. 10112934 - (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
7. 9650370 - (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
8. 9018391 - Inhibitors of beta-secretase
9. 8865744 - (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
10. 8853193 - Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
11. 8754079 - Cycloalkyl containing thienopyrimidines for pharmaceutical compositions
12. 8648068 - Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions
13. 8557782 - Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
14. 8362039 - Therapeutic uses of compounds which selectively modulate the CB2 receptor
15. 8349871 - Therapeutic uses of compounds which selectively modulate the CB2 receptor